PKI News and Press, PerkinElmer Inc. From 12/24/20

The market essentially finished flat yesterday while investors wait on a possible new stimulus plan. In the meantime, COVID cases are soaring which could lead to more testing after Christmas and New Years. This could be a boon to stocks such as Hologic, Inc. (HOLX), PerkinElmer, Inc. (PKI), a...

Our overbought indicator suggests the market could experience a 5% to 10% pullback soon. The best large-cap sectors and industries to buy, including industrials and financials. The highest-rated big-cap stocks to target on a correction. For further details see: The Best ...

PerkinElmer has been a huge beneficiary of Covid-19 thanks to its diagnostics business. Shares have done well this year, but momentum has been reasonable. Additional earnings power provides a huge windfall, as the market has been reasonably conservative in pricing/extrapolating cu...

The FDA has issued an emergency use authorization ((EUA)) to the single-use COVID-19 diagnostic test kit from Lucira Health, a California manufacturer.The Lucira COVID-19 All-In-One at home test kit provides rapid results. To date, the Agency has authorized nearly 300 test...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a Virtual Life Science Event for the investment community on Thursday, December 10 at 8:30 a.m. ET. This event is organized to serve as an in-...

With uncertainty circling the market, investors should consider safe growth stocks such as Thermo Fisher Scientific Inc (TMO), Dollar General Corporation (DG), STERIS plc (STE), and PerkinElmer, Inc. (PKI). These companies have low beta, healthy balance sheets, and a strong history of growth....

Non-invasive sample collection and batch processing to test symptomatic and asymptomatic individuals – a breakthrough in COVID-19 testing PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer ® SARS-CoV-2 Real-time RT-PCR Assay received CE...

Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN , a PerkinElmer co...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Wolfe Virtual Healthcare Conference on Thursday, November 19 at 11:25 a.m. ET. Prahlad Singh, president and chief executive officer ...

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel Virtual Healthcare Conference on Tuesday, November 17, 2020 at 1:20 p.m. ET. Jamey Mock, SVP and chief financial officer of P...